2019 · BMJ open · open access
Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1
Leiva et al.
The finding, in our words
In this pilot study, a home-based urinary PDG test achieved 100% specificity and 85-88% sensitivity for confirming ovulation against serum progesterone. With half of participants finding the test easy to use, the results support further development of decentralised fertility monitoring, though a larger trial is needed for definitive validation.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.